greeksoup/ stock research
Stock research / United States / Funds / Bleichroeder LP

Bleichroeder LP

CIK 1781002 · latest 13F filed 13 August 2026 · Read the filing on EDGAR

Bleichroeder LP reported 78 US-listed holdings worth $558.9 million in its 13F for the quarter ended 30 June 2026, filed 13 August 2026. Its largest: SPDR Gold Trust (31.3%), Gpgi, Inc. (11.3%) and SPDR S&P 500 (9.0%). Against the quarter before, it opened 9 positions, added to 7, trimmed 7 and sold out of 12.

Reported holdings$558.9M-3.4% on Q1 2026
Positions78-3 on Q1 2026
The largest ten77.5%of its reported holdings
Latest 13FQ2 2026filed 13 August 2026
Where the money is
OpenedAdded toHeldTrimmed
GLD31.3%GPGI11.3%SPY9.0%RHLD8.1%LIN5.6%DUOT3.5%DTIL2.8%CUE2.1%BX1.9%IMMX1.8%IDN1.5%SPGI1.5%INVE1.3%LIQT1.0%64 more17.2%

The 14 largest of its 78 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $371.6 million in 73 positions$372MQ3 24Q4 2024: $397.9 million in 74 positions$398MQ4 24Q1 2025: $375.3 million in 78 positions$375MQ1 25Q2 2025: $406.8 million in 76 positions$407MQ2 25Q3 2025: $513.0 million in 72 positions$513MQ3 25Q4 2025: $568.3 million in 73 positions$568MQ4 25Q1 2026: $578.6 million in 81 positions$579MQ1 26Q2 2026: $558.9 million in 78 positions$559MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +45.5% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
100120140160Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings +45.5%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 9Added 7Held 55Trimmed 7Sold out 12
Opened: 9Added: 7Held: 55Trimmed: 7Sold out: 12

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 9

  1. Cue Biopharma Inc. Com CUE$11.7 million
  2. Cogent Biosciences Inc. COGT$3.9 million
  3. Spire Global Inc. SPIR$2.5 million
  4. NeuroOne Medical Technologies Corporat NMTC$2.0 million
  5. Liberty Defense Hldgs F DETX$1.1 million
  6. Aileron Therapeutics Inc. RNTX$1.0 million
  7. Sintx Technologies Inc. SINT$978,034
  8. Heartbeam Inc. BEAT$468,750

and 1 more in the table below

Added to 7

  1. Liqtech Intl Inc. LIQT+3.7 million shares · +116%
  2. Precision Biosciences Inc. DTIL+355,690 shares · +21%
  3. Cullinan Therapeutics Inc. CGEM+150,000 shares · +150%
  4. Modular Med Inc. MODD+150,000 shares · +80%
  5. QT Imaging Hldgs Inc. QTI+150,001 shares · +90%
  6. Ideal Power Inc. Com IPWR+100,000 shares · +33%
  7. Cellectar Biosciences Inc. CLRB+188,679 shares · +189%

Trimmed 7

  1. Linde plc LIN-8,040 shares · -12%
  2. JPMorgan Chase & Co. JPM-4,800 shares · -32%
  3. Fluent Inc. FLNT-285,714 shares · -20%
  4. Pixelworks Inc. PXLW-116,746 shares · -58%
  5. Immucell Corp. ICCC-51,594 shares · -51%
  6. Intellicheck Inc. IDN-17,240 shares · -1%
  7. 5E Advanced Materials Inc. FEAM-41,226 shares · -8%

Sold out of 12

  1. Neuroone Med Technologies Co. NMTC$3.1 million last quarter
  2. Cue Biopharma Inc. CUE$1.6 million last quarter
  3. Precision Optics Corp. Inc. Mass Com New POCI$1.2 million last quarter
  4. RTX Corp. RTX$1.2 million last quarter
  5. SharonAI Holdings Inc. SHAZ$568,250 last quarter
  6. L3Harris Technologies, Inc. LHX$552,240 last quarter
  7. Ernexa Therapeutics Inc. ERNA$398,000 last quarter
  8. Carrier Global Corp. CARR$337,860 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
SPDR Gold Trust GLD475.0K$175.0 million31.31%no change
Gpgi, Inc. GPGI4.0M$63.0 million11.26%+2.5K
SPDR S&P 500 SPY67.6K$50.5 million9.04%no change
Resolute Holdings Manag RHLD314.2K$45.4 million8.12%no change
Linde plc LIN60.4K$31.4 million5.61%-8.0K
Duos Technologies Group Inc. DUOT1.6M$19.5 million3.49%no change
Precision Biosciences Inc. DTIL2.0M$15.9 million2.84%+355.7K
Cue Biopharma Inc. Com CUE370.7K$11.7 million2.09%new
Blackstone Inc. BX90.8K$10.7 million1.91%no change
Immix Biopharma Inc. IMMX1.0M$10.3 million1.84%no change
Intellicheck Inc. IDN2.1M$8.4 million1.51%-17.2K
S&P Global Inc. SPGI20.0K$8.1 million1.46%no change
Identiv Inc. INVE2.9M$7.3 million1.30%no change
Liqtech Intl Inc. LIQT6.9M$5.8 million1.05%+3.7M
Kazia Therapeutics Ltd KZIA400.0K$5.6 million1.01%no change
Envoy Medical Inc. COCH6.2M$5.0 million0.89%no change
Cullinan Therapeutics Inc. CGEM250.0K$4.6 million0.81%+150.0K
Welltower Inc. WELL20.0K$4.5 million0.81%no change
Eyepoint Pharmaceuticals Inc. EYPT316.5K$4.5 million0.81%no change
Fluent Inc. FLNT1.1M$4.3 million0.76%-285.7K
Genelux Corporation GNLX1.4M$4.2 million0.74%no change
Prokidney Corp. PROK2.0M$4.1 million0.73%no change
Cogent Biosciences Inc. COGT100.0K$3.9 million0.69%new
Invesco QQQ Trust QQQ4.6K$3.4 million0.61%no change
JPMorgan Chase & Co. JPM10.2K$3.3 million0.60%-4.8K
Mdxhealth SA MDXH7.4M$3.0 million0.54%no change
Ocuphire Pharma Inc. IRD736.8K$3.0 million0.54%no change
Grupo Televisa S A B TV1.0M$2.8 million0.50%no change
Barfresh Food Group Inc. BRFH1.4M$2.8 million0.50%no change
Diamedica Therapeutics Inc. DMAC382.3K$2.7 million0.48%no change
Rank One Computing Corp. ROC500.0K$2.6 million0.47%no change
Spire Global Inc. SPIR135.0K$2.5 million0.45%new
Ideal Power Inc. Com IPWR400.0K$2.1 million0.38%+100.0K
NeuroOne Medical Technologies Corporat NMTC666.7K$2.0 million0.36%new
Curis Inc. CRIS3.8M$2.0 million0.36%no change
Revolution Medicines Inc. RVMDW200.0K$1.9 million0.34%no change
Profound Med Corp. Com New PROF254.8K$1.7 million0.30%no change
Renovorx Inc. RNXT1.7M$1.6 million0.29%no change
Modular Med Inc. MODD337.0K$1.5 million0.27%+150.0K
Venu Hldg Corp. VENU600.0K$1.4 million0.24%no change
Talphera Inc. TLPH1.3M$1.3 million0.24%no change
QT Imaging Hldgs Inc. QTI316.7K$1.3 million0.23%+150.0K
Liberty Live Hldgs Inc. LLYVK13.8K$1.2 million0.21%no change
Liberty Defense Hldgs F DETX277.8K$1.1 million0.20%new
Aileron Therapeutics Inc. RNTX1.0M$1.0 million0.19%new
Owlet Inc. OWLT172.0K$987,2800.18%no change
Sintx Technologies Inc. SINT523.0K$978,0340.17%new
Cellectar Biosciences Inc. CLRB288.7K$802,5280.14%+188.7K
Maia Biotechnology Inc. Com MAIA500.0K$720,0000.13%no change
5E Advanced Materials Inc. FEAM458.8K$637,6960.11%-41.2K
Pixelworks Inc. PXLW84.3K$525,4170.09%-116.7K
Immucell Corp. ICCC50.0K$502,5000.09%-51.6K
Liberty Live Holdings, Inc. LLYVA6.0K$501,7190.09%no change
Heartbeam Inc. BEAT625.0K$468,7500.08%new
Sprott Asset Management LP PHYS12.5K$378,3320.07%no change
Nasus Pharma Ltd NSRX89.8K$314,4680.06%no change
Bank of New York Mellon Corp. BNY2.0K$289,2200.05%no change
Lionsgate Studios Corp. LION16.4K$251,2830.04%no change
PayPal Holdings, Inc. PYPL5.3K$228,8540.04%no change
Cadence Design Systems Inc. CDNS525$197,0430.04%no change
MultiSensor AI Holdings Inc MSAI30.6K$159,2280.03%new
Sirius XM Holdings Inc. SIRI5.1K$149,5020.03%no change
ExxonMobil Holdings Corp. XOM1.1K$146,9740.03%no change
Ernexa Therapeutics Inc. ERNAW2.0M$142,6000.03%no change
TransMedics Group, Inc. TMDX2.1K$139,4820.02%no change
Alliance Entertainment Holdi AENTW200.0K$89,0000.02%no change
ARK ETF Trust ARKF1.2K$47,3520.01%no change
ARK ETF Trust ARKW300$43,4580.01%no change
IonQ, Inc. IONQ750$39,9450.01%no change
Beyond Air Inc XAIR86.5K$38,5650.01%no change
D-Wave Quantum Inc. QBTS1.5K$35,9850.01%no change
ARK Investment Management LLC ARKG825$34,7000.01%no change
Starz Entertainment Corp. STRZ1.1K$31,5150.01%no change
Rigetti Computing, Inc. RGTI1.5K$28,9800.01%no change
GeneDx Holdings Corp. WGS304$20,8700.00%no change
Oppfi Inc.250.0K$7,5000.00%no change
X4 Pharmaceuticals Inc. XFOR595$2,7790.00%no change
Saverone 2014 Ltd SVREW121.0K$1,3310.00%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 12 it sold out of are in the box above.